Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrejs Erglis

Showing results (101-110 of 213) with videos related to

Pageof 22
Sort By:
Trials|May 14, 2026
Pitfalls in the reporting of clinical events in unblinded device trials: analysing performance bias in the BIO|GUARD-MI trialChristian Jøns, Peter Søgaard, Tom Smilde, et al.
International Journal of Cardiology|October 28, 2016
One year clinical outcomes in patients with insulin-treated diabetes mellitus and non-insulin-treated diabetes mellitus compared to non-diabetics after deployment of the bio-engineered COMBO stentDeborah N Kalkman, Pier Woudstra, Peter den Heijer, et al.
JACC. Cardiovascular Interventions|March 26, 2013
Analysis of stroke occurring in the SYNTAX trial comparing coronary artery bypass surgery and percutaneous coronary intervention in the treatment of complex coronary artery diseaseMichael J Mack, Stuart J Head, David R Holmes, et al.
JACC. Cardiovascular Interventions|May 23, 2016
1-Year Results of the REMEDEE Registry: Clinical Outcomes After Deployment of the Abluminal Sirolimus-Coated Bioengineered (Combo) Stent in a Multicenter, Prospective All-Comers RegistryPier Woudstra, Deborah N Kalkman, Peter den Heijer, et al.
Heart Rhythm O2|March 6, 2023
Diagnostic yield of an insertable cardiac monitor in a large patient populationDennis H Lau, Bertrand Pierre, Pilar Cabanas, et al.
Open Heart|August 2, 2017
Two-year clinical outcomes of patients treated with the dual-therapy stent in a 1000 patient all-comers registryDeborah N Kalkman, Pier Woudstra, Ian B A Menown, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 24, 2022
Safety and performance of a novel cerebral embolic protection device for transcatheter aortic valve implantation: the PROTEMBO C TrialDariusz Jagielak, Radoslaw Targonski, Christian Frerker, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD|March 21, 2018
Pepsinogen test for the evaluation of precancerous changes in gastric mucosa: a population-based studyOlga Sjomina, Jelizaveta Pavlova, Ilva Daugule, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|November 15, 2016
Safety and efficacy of a bioabsorbable polymer-coated, everolimus-eluting coronary stent in patients with diabetes: the EVOLVE II diabetes substudyDean J Kereiakes, Ian T Meredith, Monica Masotti, et al.
American Heart Journal|October 11, 2022
Routine revascularization with percutaneous coronary intervention in patients with coronary artery disease undergoing transcatheter aortic valve implantation - the third nordic aortic valve intervention trial - NOTION-3Muhammad Sabbah, Karsten Veien, Matti Niemela, et al.
Pageof 22

Showing results (101-110 of 213) with videos related to

Sort By:
Pageof 22
Trials|May 14, 2026
Pitfalls in the reporting of clinical events in unblinded device trials: analysing performance bias in the BIO|GUARD-MI trialChristian Jøns, Peter Søgaard, Tom Smilde, et al.
International Journal of Cardiology|October 28, 2016
One year clinical outcomes in patients with insulin-treated diabetes mellitus and non-insulin-treated diabetes mellitus compared to non-diabetics after deployment of the bio-engineered COMBO stentDeborah N Kalkman, Pier Woudstra, Peter den Heijer, et al.
JACC. Cardiovascular Interventions|March 26, 2013
Analysis of stroke occurring in the SYNTAX trial comparing coronary artery bypass surgery and percutaneous coronary intervention in the treatment of complex coronary artery diseaseMichael J Mack, Stuart J Head, David R Holmes, et al.
JACC. Cardiovascular Interventions|May 23, 2016
1-Year Results of the REMEDEE Registry: Clinical Outcomes After Deployment of the Abluminal Sirolimus-Coated Bioengineered (Combo) Stent in a Multicenter, Prospective All-Comers RegistryPier Woudstra, Deborah N Kalkman, Peter den Heijer, et al.
Heart Rhythm O2|March 6, 2023
Diagnostic yield of an insertable cardiac monitor in a large patient populationDennis H Lau, Bertrand Pierre, Pilar Cabanas, et al.
Open Heart|August 2, 2017
Two-year clinical outcomes of patients treated with the dual-therapy stent in a 1000 patient all-comers registryDeborah N Kalkman, Pier Woudstra, Ian B A Menown, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 24, 2022
Safety and performance of a novel cerebral embolic protection device for transcatheter aortic valve implantation: the PROTEMBO C TrialDariusz Jagielak, Radoslaw Targonski, Christian Frerker, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD|March 21, 2018
Pepsinogen test for the evaluation of precancerous changes in gastric mucosa: a population-based studyOlga Sjomina, Jelizaveta Pavlova, Ilva Daugule, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|November 15, 2016
Safety and efficacy of a bioabsorbable polymer-coated, everolimus-eluting coronary stent in patients with diabetes: the EVOLVE II diabetes substudyDean J Kereiakes, Ian T Meredith, Monica Masotti, et al.
American Heart Journal|October 11, 2022
Routine revascularization with percutaneous coronary intervention in patients with coronary artery disease undergoing transcatheter aortic valve implantation - the third nordic aortic valve intervention trial - NOTION-3Muhammad Sabbah, Karsten Veien, Matti Niemela, et al.
Pageof 22